| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PAVMPAVmed Inc. | 8.06M | 8.75 | 17.64 | 22.15% | -217914.55% | -245.07% | ||
| SMLRSemler Scientific, Inc. | 310.75M | 20.33 | 3.96 | -17.44% | 130.8% | 10.51% | 0.00 | |
| BJDXBluejay Diagnostics, Inc. | 1.18M | 0.65 | -0.02 | -185.51% | 0.04 | |||
| HSCSHeartSciences Inc. | 10.17M | 3.20 | -0.34 | -76.61% | -1042.38% | -216.05% | 14.55 | |
| LUCDLucid Diagnostics Inc. | 163.87M | 1.25 | -1.19 | 79% | -8.6% | -404.1% | 3.94 | |
| BMRABiomerica, Inc. | 8.09M | 2.68 | -1.24 | -1.92% | -90.29% | -90.76% | 0.11 | |
| MDAISpectral AI, Inc. | 49.41M | 1.61 | -1.89 | 63.83% | -70.64% | |||
| CODXCo-Diagnostics, Inc. | 6.12M | 2.92 | -2.35 | -42.53% | -63.36% | -80.8% | 0.04 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 12.18M | 17.59M | 22.87M | 37.63M | 56.73M | 86.38M | 110.56M | 105.52M | 121.14M | 135.44M |
| Revenue Growth % | - | 0.44% | 0.3% | 0.65% | 0.51% | 0.52% | 0.28% | -0.05% | 0.15% | 0.12% |
| Cost of Goods Sold | 6.46M | 9.84M | 12.89M | 19.65M | 29.9M | 38.2M | 45.78M | 60.16M | 48.14M | 54.32M |
| COGS % of Revenue | 0.53% | 0.56% | 0.56% | 0.52% | 0.53% | 0.44% | 0.41% | 0.57% | 0.4% | 0.4% |
| Gross Profit | 5.71M | 7.75M | 9.99M | 17.98M | 26.84M | 48.18M | 64.77M | 45.36M | 73M | 81.12M |
| Gross Margin % | 0.47% | 0.44% | 0.44% | 0.48% | 0.47% | 0.56% | 0.59% | 0.43% | 0.6% | 0.6% |
| Gross Profit Growth % | - | 0.36% | 0.29% | 0.8% | 0.49% | 0.8% | 0.34% | -0.3% | 0.61% | 0.11% |
| Operating Expenses | 20.24M | 29.46M | 35.99M | 49.07M | 68.44M | 79.77M | 121.29M | 149.63M | 118.99M | 133.74M |
| OpEx % of Revenue | 1.66% | 1.68% | 1.57% | 1.3% | 1.21% | 0.92% | 1.1% | 1.42% | 0.98% | 0.99% |
| Selling, General & Admin | 10.15M | 12.47M | 19.69M | 33.78M | 52.25M | 59.59M | 92.91M | 91.85M | 92.82M | 104.64M |
| SG&A % of Revenue | 0.83% | 0.71% | 0.86% | 0.9% | 0.92% | 0.69% | 0.84% | 0.87% | 0.77% | 0.77% |
| Research & Development | 10.08M | 16.99M | 16.3M | 15.29M | 16.19M | 20.17M | 28.38M | 26.81M | 26.06M | 31.08M |
| R&D % of Revenue | 0.83% | 0.97% | 0.71% | 0.41% | 0.29% | 0.23% | 0.26% | 0.25% | 0.22% | 0.23% |
| Other Operating Expenses | 0 | -164K | -62K | -7K | 0 | 0 | 0 | 30.97M | 99K | -1.99M |
| Operating Income | -14.52M | -21.71M | -26M | -31.55M | -41.6M | -31.58M | -56.52M | -104.26M | -45.99M | -52.62M |
| Operating Margin % | -1.19% | -1.23% | -1.14% | -0.84% | -0.73% | -0.37% | -0.51% | -0.99% | -0.38% | -0.39% |
| Operating Income Growth % | - | -0.49% | -0.2% | -0.21% | -0.32% | 0.24% | -0.79% | -0.84% | 0.56% | -0.14% |
| EBITDA | -14.1M | -21.27M | -25.52M | -30.2M | -38.59M | -27.27M | -51.64M | -98.86M | -37.7M | -44.26M |
| EBITDA Margin % | -1.16% | -1.21% | -1.12% | -0.8% | -0.68% | -0.32% | -0.47% | -0.94% | -0.31% | -0.33% |
| EBITDA Growth % | - | -0.51% | -0.2% | -0.18% | -0.28% | 0.29% | -0.89% | -0.91% | 0.62% | -0.17% |
| D&A (Non-Cash Add-back) | 425K | 444K | 482K | 1.35M | 3.01M | 4.31M | 4.88M | 5.41M | 8.29M | 8.36M |
| EBIT | -14.9M | -21.88M | -26.07M | -31.55M | -41.6M | -31.58M | -56.52M | -73.3M | -44.66M | -52.62M |
| Net Interest Income | -1.04M | -1.3M | -951K | 46K | 627K | -273K | -403K | 5.13M | 15.84M | 14.65M |
| Interest Income | 0 | 0 | 1K | 46K | 627K | 0 | 0 | 5.13M | 15.84M | 14.65M |
| Interest Expense | 1.04M | 1.3M | 952K | 0 | 0 | 273K | 403K | 0 | 0 | 0 |
| Other Income/Expense | -1.42M | -1.46M | -1.01M | 39K | 617K | -322K | 937K | 4.85M | 18.36M | 14.52M |
| Pretax Income | -15.94M | -23.17M | -27.02M | -31.05M | -40.98M | -31.91M | -55.58M | -99.41M | -27.64M | -38.1M |
| Pretax Margin % | -1.31% | -1.32% | -1.18% | -0.82% | -0.72% | -0.37% | -0.5% | -0.94% | -0.23% | -0.28% |
| Income Tax | 0 | 0 | 0 | 25K | -187K | -376K | -36K | 164K | 719K | 434K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 0.99% | 1% | 1% | 1.03% | 1.01% |
| Net Income | -15.94M | -23.17M | -27.02M | -31.05M | -40.8M | -31.53M | -55.55M | -99.57M | -28.35M | -38.53M |
| Net Margin % | -1.31% | -1.32% | -1.18% | -0.82% | -0.72% | -0.37% | -0.5% | -0.94% | -0.23% | -0.28% |
| Net Income Growth % | - | -0.45% | -0.17% | -0.15% | -0.31% | 0.23% | -0.76% | -0.79% | 0.72% | -0.36% |
| Net Income (Continuing) | -15.94M | -23.17M | -27.02M | -31.54M | -40.8M | -31.53M | -55.55M | -99.57M | -28.35M | -38.53M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -7.79 | -1.43 | -1.24 | -1.39 | -1.63 | -1.07 | -1.60 | -2.61 | -0.86 | -1.00 |
| EPS Growth % | - | 0.82% | 0.13% | -0.12% | -0.17% | 0.34% | -0.5% | -0.63% | 0.67% | -0.16% |
| EPS (Basic) | -7.79 | -1.43 | -1.24 | -1.41 | -1.63 | -1.07 | -1.60 | -2.61 | -0.86 | -1.00 |
| Diluted Shares Outstanding | 2.05M | 16.21M | 21.71M | 22.37M | 25.09M | 29.59M | 36M | 36.99M | 37.59M | 38.37M |
| Basic Shares Outstanding | 2.05M | 16.21M | 21.71M | 21.99M | 25.09M | 29.59M | 36M | 36.99M | 37.59M | 38.37M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 5.72M | 35.24M | 89.25M | 60.51M | 132.66M | 219.6M | 448.95M | 381.52M | 382.1M | 363.59M |
| Cash & Short-Term Investments | 2.32M | 29.67M | 79.68M | 45.43M | 109.16M | 181.58M | 396.46M | 338.74M | 321.32M | 289.12M |
| Cash Only | 2.32M | 29.67M | 79.68M | 45.43M | 109.16M | 181.58M | 396.46M | 338.74M | 174.42M | 56.71M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 146.9M | 232.41M |
| Accounts Receivable | 2.26M | 3.92M | 5.6M | 6.79M | 10.91M | 17.18M | 23.79M | 19.02M | 25.41M | 32.14M |
| Days Sales Outstanding | 67.79 | 81.3 | 89.34 | 65.88 | 70.16 | 72.61 | 78.53 | 65.78 | 76.57 | 86.62 |
| Inventory | 1M | 1.53M | 3.57M | 5.96M | 10.46M | 14.86M | 22.19M | 16.96M | 26.12M | 32.77M |
| Days Inventory Outstanding | 56.57 | 56.7 | 101.14 | 110.76 | 127.73 | 141.97 | 176.9 | 102.92 | 198.05 | 220.24 |
| Other Current Assets | 0 | 127K | 400K | 2.33M | 0 | 0 | 6.51M | 6.8M | 9.23M | 9.56M |
| Total Non-Current Assets | 1.63M | 1.87M | 2.53M | 7.12M | 37.29M | 51.44M | 57.56M | 52.06M | 46.47M | 42.94M |
| Property, Plant & Equipment | 1.08M | 1.22M | 1.87M | 2.92M | 12.05M | 25.91M | 29.45M | 41.03M | 36.18M | 33.49M |
| Fixed Asset Turnover | 11.28x | 14.38x | 12.21x | 12.87x | 4.71x | 3.33x | 3.75x | 2.57x | 3.35x | 4.04x |
| Goodwill | 0 | 0 | 0 | 1.31M | 9.35M | 10.46M | 9.63M | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 2.35M | 14.31M | 13.72M | 10.53M | 7.52M | 6.03M | 4.03M |
| Long-Term Investments | 600K | 400K | 653K | 1M | 1.03M | 0 | 2.58M | 2.6M | 0 | 0 |
| Other Non-Current Assets | -49K | 251K | -1K | 536K | -1.67M | 1.36M | 378K | -6.86M | 4.26M | 5.42M |
| Total Assets | 7.35M | 37.12M | 91.78M | 67.63M | 169.95M | 271.05M | 506.51M | 433.58M | 428.57M | 406.53M |
| Asset Turnover | 1.66x | 0.47x | 0.25x | 0.56x | 0.33x | 0.32x | 0.22x | 0.24x | 0.28x | 0.33x |
| Asset Growth % | - | 4.05% | 1.47% | -0.26% | 1.51% | 0.59% | 0.87% | -0.14% | -0.01% | -0.05% |
| Total Current Liabilities | 7.79M | 10.96M | 19.71M | 17.66M | 19.83M | 39.8M | 36.98M | 31.35M | 38.98M | 42.01M |
| Accounts Payable | 1.35M | 2.55M | 3.55M | 5.11M | 5.78M | 6.8M | 9.21M | 3.84M | 5.05M | 6.95M |
| Days Payables Outstanding | 75.99 | 94.58 | 100.6 | 94.93 | 70.53 | 64.97 | 73.42 | 23.27 | 38.27 | 46.72 |
| Short-Term Debt | 2.08M | 899K | 5.04M | 0 | 75K | 7.67M | 1.43M | 2.69M | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 1.34M | 2.39M | 3.56M | 3.13M | 2.71M | 13.83M | 6.73M | 5.15M | 14.17M | 12.62M |
| Current Ratio | 0.73x | 3.22x | 4.53x | 3.43x | 6.69x | 5.52x | 12.14x | 12.17x | 9.80x | 8.66x |
| Quick Ratio | 0.61x | 3.08x | 4.35x | 3.09x | 6.16x | 5.14x | 11.54x | 11.63x | 9.13x | 7.88x |
| Cash Conversion Cycle | 48.36 | 43.42 | 89.88 | 81.7 | 127.37 | 149.61 | 182.02 | 145.43 | 236.35 | 260.14 |
| Total Non-Current Liabilities | 14.76M | 12.69M | 6.2M | 8.41M | 21.46M | 25.12M | 28.59M | 44.3M | 39.63M | 34.49M |
| Long-Term Debt | 7.65M | 9.34M | 4.35M | 7.62M | 7.59M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | -5.55M | -2.8M | 0 | 0 | 0 | 21.89M | 20.46M | 41.42M | 37.22M | 32.62M |
| Deferred Tax Liabilities | 5.55M | 2.8M | 0 | 0 | 2.83M | 2.65M | 7.02M | 9.24M | 1.18M | 800K |
| Other Non-Current Liabilities | 200K | -2.59M | 144K | 278K | 10.58M | 0 | 0 | -7.77M | 0 | 0 |
| Total Liabilities | 22.55M | 23.64M | 25.91M | 26.07M | 41.29M | 64.92M | 65.56M | 75.65M | 78.61M | 76.5M |
| Total Debt | 9.73M | 10.24M | 9.38M | 7.62M | 7.66M | 30.8M | 21.89M | 44.1M | 41.46M | 37.37M |
| Net Debt | 7.4M | -19.43M | -70.3M | -37.81M | -101.49M | -150.79M | -374.57M | -294.64M | -132.96M | -19.34M |
| Debt / Equity | - | 0.76x | 0.14x | 0.18x | 0.06x | 0.15x | 0.05x | 0.12x | 0.12x | 0.11x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -13.96x | -16.73x | -27.32x | - | - | -115.69x | -140.25x | - | - | - |
| Total Equity | -15.2M | 13.48M | 65.87M | 41.56M | 128.66M | 206.13M | 440.95M | 357.93M | 349.96M | 330.04M |
| Equity Growth % | - | 1.89% | 3.89% | -0.37% | 2.1% | 0.6% | 1.14% | -0.19% | -0.02% | -0.06% |
| Book Value per Share | -7.42 | 0.83 | 3.03 | 1.86 | 5.13 | 6.97 | 12.25 | 9.68 | 9.31 | 8.60 |
| Total Shareholders' Equity | -15.2M | 13.48M | 65.87M | 41.56M | 128.66M | 206.13M | 440.95M | 357.93M | 349.96M | 330.04M |
| Common Stock | 2K | 2K | 22K | 22K | 28K | 32K | 37K | 37K | 38K | 39K |
| Retained Earnings | -88.64M | -115.11M | -144.35M | -175.89M | -216.24M | -247.77M | -305.46M | -403.2M | -431.55M | -470.08M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.58M | -1.96M | -2.42M | -3.02M | -153K | 2.43M | 441K | -2.54M | -1.67M | -3.08M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -12.52M | -17.74M | -22.11M | -28.72M | -26.19M | -23.36M | -47.91M | -48.27M | -18.9M | -35.16M |
| Operating CF Margin % | -1.03% | -1.01% | -0.97% | -0.76% | -0.46% | -0.27% | -0.43% | -0.46% | -0.16% | -0.26% |
| Operating CF Growth % | - | -0.42% | -0.25% | -0.3% | 0.09% | 0.11% | -1.05% | -0.01% | 0.61% | -0.86% |
| Net Income | -15.94M | -23.17M | -27.02M | -31.54M | -40.8M | -31.53M | -57.69M | -96.7M | -32.33M | -38.53M |
| Depreciation & Amortization | 425K | 444K | 482K | 1.35M | 3.01M | 4.31M | 4.85M | 5.35M | 8.38M | 8.36M |
| Stock-Based Compensation | 1.1M | 928K | 2.17M | 4.88M | 6.39M | 10.1M | 15.97M | 15.44M | 16.76M | 19.99M |
| Deferred Taxes | 598K | 318K | 90K | -14K | 140K | 416K | 801K | -226K | 0 | 0 |
| Other Non-Cash Items | 306K | 2.47M | 238K | 170K | 700K | 808K | 340K | 25.79M | 92K | -6.19M |
| Working Capital Changes | 993K | 1.27M | 1.94M | -3.58M | 4.37M | -7.47M | -12.19M | 2.07M | -11.8M | -18.79M |
| Change in Receivables | -1.47M | -1.66M | -1.68M | -983K | -3.37M | -6.24M | -6.85M | 5.16M | -6.7M | -7.7M |
| Change in Inventory | -254K | -526K | -2.04M | -1.6M | -3.45M | -5.12M | -8.09M | 5.39M | -5.36M | -6.68M |
| Change in Payables | 542K | 1.13M | 1M | 1.32M | 621K | 649K | 2.41M | -5.36M | 1.19M | 723K |
| Cash from Investing | -554K | -826K | -1.13M | -5.45M | -25.38M | -626K | -6.34M | -11.21M | -148.4M | -82.27M |
| Capital Expenditures | -597K | -526K | -1.13M | -1.52M | -10.85M | -3.93M | -13.62M | -11.73M | -3.79M | -3.37M |
| CapEx % of Revenue | 0.05% | 0.03% | 0.05% | 0.04% | 0.19% | 0.05% | 0.12% | 0.11% | 0.03% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 43K | 0 | 0 | 15K | 0 | 3.3M | 7.28M | 520K | 0 | 0 |
| Cash from Financing | 11.7M | 45.92M | 73.25M | -78K | 116.2M | 96.24M | 270.8M | 2.31M | 2.69M | 456K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 43K | 231K | 231K | 1.87M | 3.7M | 4.91M | 8.81M | 0 | -198K | -2.61M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -13.11M | -18.27M | -23.24M | -30.24M | -37.03M | -27.3M | -61.52M | -60M | -22.69M | -38.53M |
| FCF Margin % | -1.08% | -1.04% | -1.02% | -0.8% | -0.65% | -0.32% | -0.56% | -0.57% | -0.19% | -0.28% |
| FCF Growth % | - | -0.39% | -0.27% | -0.3% | -0.22% | 0.26% | -1.25% | 0.02% | 0.62% | -0.7% |
| FCF per Share | -6.41 | -1.13 | -1.07 | -1.35 | -1.48 | -0.92 | -1.71 | -1.62 | -0.60 | -1.00 |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.77x | 0.82x | 0.93x | 0.64x | 0.74x | 0.86x | 0.48x | 0.67x | 0.91x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684K | 808K | 875K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -171.96% | -68.11% | -57.8% | -47.94% | -18.84% | -17.17% | -24.93% | -8.01% | -11.33% |
| Return on Invested Capital (ROIC) | - | - | - | -631% | -201.84% | -57.42% | -69.65% | -120.61% | -24.61% | -14.96% |
| Gross Margin | 46.92% | 44.06% | 43.66% | 47.79% | 47.3% | 55.78% | 58.59% | 42.99% | 60.26% | 59.89% |
| Net Margin | -130.89% | -131.78% | -118.12% | -82.5% | -71.91% | -36.5% | -50.24% | -94.36% | -23.41% | -28.45% |
| Debt / Equity | - | 0.76x | 0.14x | 0.18x | 0.06x | 0.15x | 0.05x | 0.12x | 0.12x | 0.11x |
| Interest Coverage | -13.96x | -16.73x | -27.32x | - | - | -115.69x | -140.25x | - | - | - |
| FCF Conversion | 0.79x | 0.77x | 0.82x | 0.93x | 0.64x | 0.74x | 0.86x | 0.48x | 0.67x | 0.91x |
| Revenue Growth | - | 44.38% | 30.08% | 64.52% | 50.76% | 52.25% | 27.99% | -4.55% | 14.8% | 11.8% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Product | 23.36M | 720K | 580K | - | - | - | 79.74M |
| Product Growth | - | -96.92% | -19.44% | - | - | - | - |
| Service And Other Revenue | - | - | - | - | - | - | 51.24M |
| Service And Other Revenue Growth | - | - | - | - | - | - | - |
| License and Service | - | - | - | - | - | - | 4.45M |
| License and Service Growth | - | - | - | - | - | - | - |
| Grant | - | - | - | - | - | - | 1.99M |
| Grant Growth | - | - | - | - | - | - | - |
| Product revenue | - | - | - | 505K | 2.63M | 32.64M | - |
| Product revenue Growth | - | - | - | - | 421.58% | 1139.03% | - |
| Service revenue. | - | - | - | - | - | 19.09M | - |
| Service revenue. Growth | - | - | - | - | - | - | - |
| Service-type warranties and research services | - | - | - | 7M | 9.6M | - | - |
| Service-type warranties and research services Growth | - | - | - | - | 37.14% | - | - |
| Undelivered licenses of intellectual property | - | - | - | 500K | 500K | - | - |
| Undelivered licenses of intellectual property Growth | - | - | - | - | 0.00% | - | - |
| Service and other revenue | - | - | - | 114K | 11K | - | - |
| Service and other revenue Growth | - | - | - | - | -90.35% | - | - |
| Undelivered Services Related To Initial And Extended Service Type Warranties And Research Services | - | 3M | 4.9M | - | - | - | - |
| Undelivered Services Related To Initial And Extended Service Type Warranties And Research Services Growth | - | - | 63.33% | - | - | - | - |
| Undelivered Licenses Of Intellectual Property | - | 1.7M | 500K | - | - | - | - |
| Undelivered Licenses Of Intellectual Property Growth | - | - | -70.59% | - | - | - | - |
| Service Other | 12.12M | 118K | 202K | - | - | - | - |
| Service Other Growth | - | -99.03% | 71.19% | - | - | - | - |
| License And Service | 2.15M | - | - | - | - | - | - |
| License And Service Growth | - | - | - | - | - | - | - |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| North America | 22.71M | 3.14M | 3.17M | - | - | - | 43.72M |
| North America Growth | - | -86.18% | 1.02% | - | - | - | - |
| EMEA | - | - | - | 2.04M | 2.78M | 25.51M | 24.62M |
| EMEA Growth | - | - | - | - | 36.29% | 818.03% | -3.51% |
| Asia Pacific | 3.18M | 171K | 207K | 255K | 480K | 12.56M | 11.4M |
| Asia Pacific Growth | - | -94.63% | 21.05% | 23.19% | 88.24% | 2515.83% | -9.17% |
| E M E A | 11.74M | 1.32M | 1.54M | - | - | - | - |
| E M E A Growth | - | -88.73% | 16.63% | - | - | - | - |
Quanterix Corporation (QTRX) reported $129.0M in revenue for fiscal year 2024. This represents a 959% increase from $12.2M in 2015.
Quanterix Corporation (QTRX) grew revenue by 11.8% over the past year. This is steady growth.
Quanterix Corporation (QTRX) reported a net loss of $95.7M for fiscal year 2024.
Quanterix Corporation (QTRX) has a return on equity (ROE) of -11.3%. Negative ROE indicates the company is unprofitable.
Quanterix Corporation (QTRX) had negative free cash flow of $68.2M in fiscal year 2024, likely due to heavy capital investments.